AMGN · Categories · Upgrades
AMGN - Analyst upgrades
Amgen Inc. (AMGN) analyst upgrades - real-time wire coverage filtered to Upgrades only.
Recent Upgrades for AMGN
- Amgen upgraded by Erste GroupErste Group upgraded Amgen from Hold to Buy
- Amgen upgraded by Barclays with a new price targetBarclays upgraded Amgen from Underweight to Equal Weight and set a new price target of $300.00 from $230.00 previously
- Amgen upgraded by William BlairWilliam Blair upgraded Amgen from Mkt Perform to Outperform
- Amgen upgraded by Daiwa Securities with a new price targetDaiwa Securities upgraded Amgen from Neutral to Buy and set a new price target of $320.00 from $264.00 previously
- Amgen upgraded by BMO Capital Markets with a new price targetBMO Capital Markets upgraded Amgen from Market Perform to Outperform and set a new price target of $326.00 from $286.00 previously
- Amgen upgraded by RBC Capital Mkts with a new price targetRBC Capital Mkts upgraded Amgen from Sector Perform to Outperform and set a new price target of $300.00 from $256.00 previously
- Amgen upgraded by Truist with a new price targetTruist upgraded Amgen from Hold to Buy and set a new price target of $320.00 from $260.00 previously
- Amgen upgraded by Wells Fargo with a new price targetWells Fargo upgraded Amgen from Equal Weight to Overweight and set a new price target of $265.00 from $275.00 previously
- Amgen upgraded by Morgan Stanley with a new price targetMorgan Stanley upgraded Amgen from Equal-Weight to Overweight and set a new price target of $279.00 from $257.00 previously